Acute confusional state after designer tryptamine abuse

Masanari Itokawa(Fujita Health University), Masahiro Shintani(Tokyo Metropolitan Hiroo Hospital), Ichiro Yasuda(University of Toyama), MINARI UNO(Tokyo Metropolitan Hiroo Hospital), KIKUE INOUE(Tokyo Metropolitan Hiroo Hospital), GEN‐ICHI SUGIHARA(Tokyo Metropolitan Hiroo Hospital), Daisuke Jitoku(Tokyo Metropolitan Hiroo Hospital), Takeshi Sasaki(Tokyo Metropolitan Hiroo Hospital), Mizue Hobo(Tokyo Metropolitan Hiroo Hospital), Ken Iwata(Tokyo Metropolitan Hiroo Hospital), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Yuichiro Abe(Tokyo Metropolitan Hiroo Hospital), Misako Takahashi(Tokyo Metropolitan Institute of Public Health)
Psychiatry and Clinical Neurosciences
March 14, 2007
10.1111/j.1440-1819.2007.01638.x
Cited by 60

Related Papers

Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326
Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights
|Cell Reports|2018|264
Consensus guidelines on the optimal management in interventional EUS procedures: results from the Asian EUS group RAND/UCLA expert panel
|Gut|2018|212
Brain Cannabinoid CB2 Receptor in Schizophrenia
|Biological Psychiatry|2009|184